Sang Gu Hwang
Inventor
Stats
- 1 US patents issued
- 5 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 1 US Patents Issued
- 5 US Applications Filed
- 0 Total Citation Count
- Feb 17, 2021 Most Recent Filing
- Jan 22, 2010 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| KOREA INSTITUTE OF RADIOLOGICAL & MEDICAL SCIENCES | 1
1 | 2010
2014 |
Inventor Addresses
| Address | Duration |
|---|---|
| Seoul, KR | Feb 09, 12 - Jul 09, 24 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A23L: | FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT | 1 |
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 3 |
| A61N: | ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY | 1 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 12029730 | 2024 | Pharmaceutical composition for preventing or treating cancer, containing N-1H-benzimidazol-2-yl-3-(1H-pyrrole-1-yl)benzamide as active ingredient | 0 |
| 2023/0099,264 | 2023 | Biomarker for Predicting Prognosis of Radiotherapy for Lung Cancer | 0 |
| 2021/0379,022 | 2021 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, CONTAINING N-1H-BENZIMIDAZOL-2-YL-3-(1H-PYRROLE-1-YL)BENZAMIDE AS ACTIVE INGREDIENT | 0 |
| 10301596 | 2019 | Method of repairing damaged chondrocytes via low-dose irradiation | 0 |
| 9963701 | 2018 | Pharmaceutical composition for treatment of radiation- or drug-resistant cancer comprising HRP-3 inhibitor | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.